Press Digest: Financial Times - Aug 8

Crispr Therapeutics AG

08/08/2024 04:09

Aug 8 (Reuters) - The following are the top stories in
the Financial Times. Reuters has not verified these stories and
does not vouch for their accuracy.
    
    Headlines
- NHS in England to roll out 1.7 mln pound Crispr gene editing
drug
- Ministry of Defence asks suppliers to identify budget cuts
- H2O Asset Management to pay investors 250 mln euros after FCA
finds 'serious breaches'
- UK signals move to curb overseas hiring for tech and
engineering jobs
        
    
    Overview
- Britain's National Health Service (NHS) will begin to roll out
a gene therapy from Vertex Pharmaceuticals  VRTX.O  and CRISPR
Therapeutics  CRSP.BN  to treat rare blood disorder beta
thalassemia. 
- The British Ministry of Defence has asked all major industry
suppliers to identify opportunities for immediate budget cuts.
- Asset manager H2O has voluntarily offered to pay 250 million
euros ($273.30 million) to investors trapped in funds since 2020
and will shut its UK operation.   
- The UK government has signalled it wants to curb overseas
hiring by engineering and technology companies, after it asked
independent advisers to review the reliance of the sector on
skilled worker visas.     


($1 = 0.9147 euros)

 (Compiled by Bengaluru newsroom)
 ((globalnewsmonitoring@thomsonreuters.com))